flaky skin on your scalp. Dandruff typically appears as general flaking, but psoriasis develops from a clearly defined plaque (thick patch of skin). Psoriasis plaques can be white or grey and turn ...

Risankizumab was associated with more significant improvements among patients with plaque psoriasis when compared with other biologic therapies.

according to the analysis of patients with plaque psoriasis. “We typically don’t think about putting cream on the scalp,” she added, but additional research looking at this PAD-formulated ...

Generalized pustular psoriasis is a very rare and extreme form of psoriasis. It’s characterized by reoccurring flare-ups that cause pus-filled bumps and red or discolored skin over a large part ...

Adults taking the novel once-daily oral pill for plaque psoriasis have significantly higher rates of clear or almost clear ...

The first poster was based on findings from the PSORIATYK SCALP (NCT05478499 ... the treatment of adults with moderate to severe plaque psoriasis who are candidates for systemic therapy.

Adults and adolescents treated with icotrokinra experienced improvements in their moderate to severe plaque psoriasis, ...

Topline results from Phase 3 ICONIC-ADVANCE 1&2�studies show icotrokinra achieved co-primary endpoints and showed superiority to deucravacitinib in moderate-to-severe plaque PsO ...

ZORYVE cream, 0.3%, is indicated for topical treatment of plaque psoriasis ... based on the PDUFA for the treatment of scalp and body psoriasis, the potential for clinical results for ZORYVE ...

Once-daily ICP-488 significantly improved PASI scores in patients with plaque psoriasis compared with placebo at week 12. The safety profile of ICP-488 was similar to placebo. ORLANDO — A once ...

The most common adverse reactions (≥1%) for ZORYVE cream 0.3% for plaque psoriasis include diarrhea (3.1 ... for FDA approval based on the PDUFA for the treatment of scalp and body psoriasis, the ...